Abstract
A retrospective chart review to assess the efficacy and tolerability of switching from an alternative brand of IVIG to Panzyga® in patients with autoimmune neuromuscular disorders (P3.4-032)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have